Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00790530 · ClinicalTrials.gov registry record · NA

Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

A NA study, sponsored by Harvard Pilgrim Health Care.

Completed
Registry status
NA
Development phase
1,200
Enrollment target

NCT00790530: Completed NA study, sponsored by Harvard Pilgrim Health Care.

NCT00790530 is a NA study that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 1,200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00790530, a NA study, has completed, sponsored by Harvard Pilgrim Health Care.

COMPLETED
Registry status
NA
Development phase
1,200 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Automated Telephone Outreach with Speech Recognition

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2006-06
Est. Completion 2007-10
Phase NA
Harvard Pilgrim Health Care

28 total trials

What the finished NCT00790530 record still lists

NCT00790530 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT00790530 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00790530 about?

NCT00790530 is a clinical study titled "Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study". The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.

What is the current status of trial NCT00790530?

This trial is currently completed. It is a NA study. The enrollment target is 1,200 participants. The study started on 2006-06. Estimated completion is 2007-10.

What interventions are being tested in trial NCT00790530?

The interventions under investigation include: Usual Care (OTHER), Automated Telephone Outreach with Speech Recognition (BEHAVIORAL).

Who is sponsoring clinical trial NCT00790530?

This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00790530's enrollment target sits among peer trials

1,200 83rd of 2000 higher than 1,912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00790530, the US trial registry maintained by the National Library of Medicine. NCT00790530 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.